OncoMed Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch OMED and buy or sell other stocks, ETFs, and their options commission-free!

About OMED

OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as “cancer stem cells“. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.

CEO

John A. Lewicki, PhD

CEOJohn A. Lewicki, PhD

Employees

—

Employees—

Headquarters

Mountain View, California

HeadquartersMountain View, California

Founded

2004

Founded2004

Employees

—

Employees—

OMED Key Statistics

Market cap

34.41M

Market cap34.41M

Price-Earnings ratio

-4.21

Price-Earnings ratio-4.21

Dividend yield

—

Dividend yield—

Average volume

1.23M

Average volume1.23M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$3.35

52 Week high$3.35

52 Week low

$0.5467

52 Week low$0.5467